Addiction - OPEN Foundation

The tripping point: The potential role of psychedelic-assisted therapy in the response to the opioid crisis

Argento, E., Tupper, K. W., & Socias, M. E. | International Journal of Drug Policy | 7 February 2019

A systematic study of microdosing psychedelics

Polito, V., & Stevenson, R. J. | PloS one | 6 February 2019

Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats

Sakloth, F., Leggett, E., Moerke, M. J., Townsend, E. A., Banks, M. L., & Negus, S. S. | Experimental and clinical psychopharmacology | 10 January 2019

Association of Combined Naltrexone and Ketamine With Depressive Symptoms in a Case series of Patients With Depression and Alcohol Use Disorder

Yoon, G., Petrakis, I. L., & Krystal, J. H. | JAMA psychiatry | 9 January 2019

Metabolite Profiling of Antiaddictive Alkaloids from Four Mexican Tabernaemontana Species and the Entheogenic African Shrub Tabernanthe iboga (Apocynaceae)

Krengel, F., Chevalier, Q., Dickinson, J., Santoyo, J. H., & Reyes-Chilpa, R. | Chemistry & biodiversity | 7 January 2019

Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence

Knuijver, T., Belgers, M., Markus, W., Verkes, R. J., van Oosteren, T., & Schellekens, A. | Journal of clinical psychopharmacology | 1 December 2018

A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder

Barsuglia, J. P., Polanco, M., Palmer, R., Malcolm, B. J., Kelmendi, B., & Calvey, T. | Progress in brain research | 25 October 2018

Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers.

Corkery, J. M. | Progress in brain research | 12 October 2018

DARK Classics in Chemical Neuroscience: Ibogaine.

Wasko, M. J., Witt-Enderby, P. A., & Surratt, C. K. | ACS chemical neuroscience | 9 October 2018

LSD Administered as a Single Dose Reduces Alcohol Consumption in C57BL/6J Mice.

Alper, K., Dong, B., Shah, R., Sershen, H., & Vinod, K. Y. | Frontiers in pharmacology | 31 August 2018

Therapeutic Potential Ascribed to Ayahuasca by Users in the Czech Republic

Horák, M., Hasíková, L., & Verter, N. | Journal of psychoactive drugs | 30 August 2018

A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification

Davis, A. K., Renn, E., Windham-Herman, A. M., Polanco, M., & Barsuglia, J. P. | Journal of psychoactive drugs | 18 July 2018

Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts

Noorani, T., Garcia-Romeu, A., Swift, T. C., Griffiths, R. R., & Johnson, M. W. | Journal of Psychopharmacology | 25 June 2018

Ibogaine Detoxification Transitions Opioid and Cocaine Abusers Between Dependence and Abstinence: Clinical Observations and Treatment Outcomes

Mash, D. C., Duque, L., Page, B., & Allen-Ferdinand, K. | Frontiers in Pharmacology | 5 June 2018

Psychedelic therapy as a complementary treatment approach for alcohol use disorders

Eischens, P., & Atherton, W. L. | Journal of Psychedelic Studies | 30 May 2018

Ayahuasca and Its DMT- and β-carbolines – Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment

Cata-Preta, E. G., Serra, Y. A., Moreira-Junior, E. D. C., Reis, H. S., Kisaki, N. D., Libarino-Santos, M., ... & Costa, J. L. | Frontiers in pharmacology | 29 May 2018

The epidemiology of 5-methoxy- N,N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. | Journal of Psychopharmacology | 30 April 2018

Assessment of Alcohol and Tobacco Use Disorders Among Religious Users of Ayahuasca.

Ribeiro Barbosa, P. C., Tofoli, L. F., Bogenschutz, M. P., Hoy, R., Berro, L. F., Marinho, E. A., ... & Winkelman, M. J. | Frontiers in psychiatry | 24 April 2018

Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine

Malcolm, B. J., Polanco, M., & Barsuglia, J. P. | Journal of psychoactive drugs | 2 April 2018

Ceremonial ‘Plant Medicine’ use and its relationship to recreational drug use: an exploratory study

Dorsen, C., Palamar, J., & Shedlin, M. G. | Addiction Research & Theory | 30 March 2018

Sex differences in sub-anesthetic ketamine’s antidepressant effects and abuse liability.

Wright, K. N., & Kabbaj, M. | Current opinion in behavioral sciences | 2 March 2018

The Psychedelic Debriefing in Alcohol Dependence Treatment: Illustrating Key Change Phenomena through Qualitative Content Analysis of Clinical Sessions

Nielson, E. M., May, D. G., Forcehimes, A. A., & Bogenschutz, M. P. | Frontiers in Pharmacology | 21 February 2018